May 13, 2026 08:39AM
May 13, 2026 08:39AM
May 12, 2026 07:00PM
May 5, 2026 06:02AM
May 5, 2026 06:00AM
Apr 28, 2026 06:00AM
Jan 22, 2026 04:02PM Anteris receives $90 million strategic investment from Medtronic
Jan 22, 2026 04:02PM
Jan 22, 2026 04:01PM
Jan 22, 2026 04:01PM
Jan 20, 2026 10:54PM
Jan 20, 2026 10:53PM
Jan 20, 2026 10:53PM
Jan 20, 2026 10:53PM Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
Nov 12, 2025 05:52PM
Oct 28, 2025 06:08PM
Oct 27, 2025 05:55PM
Oct 27, 2025 05:43PM
Oct 27, 2025 08:43AM
Oct 15, 2025 09:18AM
Oct 15, 2025 09:18AM Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
Sep 19, 2025 02:30AM
Sep 11, 2025 08:50AM
Sep 4, 2025 01:42AM
Aug 11, 2025 04:52PM
Jun 9, 2025 10:52PM
May 13, 2025 05:45PM
Mar 31, 2025 07:16AM Anteris Technologies Global (AVR) Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR THV
Mar 31, 2025 07:15AM
Mar 21, 2025 07:32AM
Mar 12, 2025 08:33PM
Dec 16, 2024 07:49PM
Aug 9, 2023 06:00AM
Feb 15, 2023 08:00AM
Nov 28, 2022 08:00AM Anteris Technologies Receives FDA Clearance to Initiate Early Feasibility Study for its Novel TAVR Product, DurAVR™
Sep 13, 2022 05:30AM
Sep 13, 2022 05:30AM
Mar 2, 2022 05:30AM
Jun 1, 2020 05:30AM

322,885 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All